Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (4293)	4/17/2003 1:43:01 PM
From: fred hayes	Read Replies (1) \| Respond to of 10345

>>.. the letter to the editor lacks rigor<< Looks like Behan is the same guy that attacked interferon beta therapy as being ineffective and claims that MS is not an autoimmune disease. We had this discussio back in December. At that time, someone was kind enough to write a response that seemed to indicate Mr Behan may not be too good of a source. I sure believe the evidence seems to support interferon beta therapy as being beneficial, so I kinda discount what these folks now have to say about Antegren. Message 18292357